Safety and immunogenicity of candidate vaccine M72/AS01(E) in adolescents in a TB endemic setting

BACKGROUND: Vaccination that prevents tuberculosis (TB) disease, particularly in adolescents, would have the greatest impact on the global TB epidemic. Safety, reactogenicity and immunogenicity of the vaccine candidate M72/AS01(E) was evaluated in healthy, HIV-negative adolescents in a TB endemic re...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Vaccine
Main Authors: Penn-Nicholson, Adam, Geldenhuys, Hennie, Burny, Wivine, van der Most, Robbert, Day, Cheryl L., Jongert, Erik, Moris, Philippe, Hatherill, Mark, Ofori-Anyinam, Opokua, Hanekom, Willem
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5845829/
https://ncbi.nlm.nih.gov/pubmed/26072017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2015.05.088
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares